CN114514022A - 维持生活活动量、预防其降低、抑制或改善其降低用组合物 - Google Patents
维持生活活动量、预防其降低、抑制或改善其降低用组合物 Download PDFInfo
- Publication number
- CN114514022A CN114514022A CN202080069358.3A CN202080069358A CN114514022A CN 114514022 A CN114514022 A CN 114514022A CN 202080069358 A CN202080069358 A CN 202080069358A CN 114514022 A CN114514022 A CN 114514022A
- Authority
- CN
- China
- Prior art keywords
- activity
- amount
- reduction
- living
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 176
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 230000009467 reduction Effects 0.000 title claims abstract description 65
- 230000003405 preventing effect Effects 0.000 title claims abstract description 45
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 21
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 claims description 102
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 claims description 93
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 claims description 52
- 230000007423 decrease Effects 0.000 claims description 49
- 235000013305 food Nutrition 0.000 claims description 37
- 239000003814 drug Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 15
- 235000013402 health food Nutrition 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 235000013376 functional food Nutrition 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 description 19
- 230000037081 physical activity Effects 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 15
- 230000036541 health Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 241000700159 Rattus Species 0.000 description 7
- 239000008159 sesame oil Substances 0.000 description 7
- 235000011803 sesame oil Nutrition 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000001133 acceleration Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- -1 lignan compounds Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XNWFXTOHNKPYMK-UHFFFAOYSA-N 3,3a,4,5,6,6a-hexahydrocyclopenta[c]dioxole Chemical class C1OOC2CCCC21 XNWFXTOHNKPYMK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000252210 Cyprinidae Species 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 241000282567 Macaca fascicularis Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 241000269796 Seriola quinqueradiata Species 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 241001515942 marmosets Species 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 1
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019-183905 | 2019-10-04 | ||
JP2019183905 | 2019-10-04 | ||
PCT/JP2020/035986 WO2021065664A1 (fr) | 2019-10-04 | 2020-09-24 | Composition pour maintenir ou améliorer la quantité d'activité de vie quotidienne, ou pour prévenir ou supprimer une diminution de la quantité d'activité de vie quotidienne |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114514022A true CN114514022A (zh) | 2022-05-17 |
Family
ID=75337310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080069358.3A Pending CN114514022A (zh) | 2019-10-04 | 2020-09-24 | 维持生活活动量、预防其降低、抑制或改善其降低用组合物 |
Country Status (4)
Country | Link |
---|---|
JP (2) | JPWO2021065664A1 (fr) |
CN (1) | CN114514022A (fr) |
TW (1) | TW202123954A (fr) |
WO (1) | WO2021065664A1 (fr) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1796388A (zh) * | 2004-12-28 | 2006-07-05 | 三得利株式会社 | 芝麻素/异芝麻素组合物 |
WO2009038089A1 (fr) * | 2007-09-19 | 2009-03-26 | Suntory Holdings Limited | Agent anti-fatigue contenant de la sésamine et de la vitamine e |
JP2009073749A (ja) * | 2007-09-19 | 2009-04-09 | Suntory Ltd | セサミン類とγ−オリザノールとを含有する組成物 |
CN101801370A (zh) * | 2007-09-19 | 2010-08-11 | 三得利控股株式会社 | 含有芝麻素类和花生四烯酸类的组合物 |
CN101868238A (zh) * | 2007-09-19 | 2010-10-20 | 三得利控股株式会社 | 配合有芝麻素类和维生素b1类的组合物 |
JP2015096494A (ja) * | 2013-10-07 | 2015-05-21 | かどや製油株式会社 | 生体内酸化還元状態改善剤 |
US20180071248A1 (en) * | 2015-03-23 | 2018-03-15 | Suntory Holdings Limited | Composition for improving circadian rhythm |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3342409A1 (fr) * | 2007-03-15 | 2018-07-04 | Suntory Holdings Limited | Agent anti-fatigue |
JP2011063552A (ja) * | 2009-09-18 | 2011-03-31 | Hokkaido Univ | 身体活動促進剤 |
JP2014051459A (ja) * | 2012-09-07 | 2014-03-20 | Nof Corp | 脂質代謝促進剤 |
KR101488612B1 (ko) * | 2013-08-12 | 2015-01-30 | 주식회사 엘지생활건강 | 흑색 식품소재를 함유하는 건강식품 및 약학적 조성물 |
JP6071988B2 (ja) * | 2014-12-09 | 2017-02-01 | 国立大学法人北海道大学 | 身体活動促進剤 |
JP6420797B2 (ja) * | 2015-08-07 | 2018-11-07 | 国立大学法人 筑波大学 | 活動意欲向上剤 |
-
2020
- 2020-09-24 JP JP2021551148A patent/JPWO2021065664A1/ja active Pending
- 2020-09-24 WO PCT/JP2020/035986 patent/WO2021065664A1/fr active Application Filing
- 2020-09-24 CN CN202080069358.3A patent/CN114514022A/zh active Pending
- 2020-09-29 TW TW109133795A patent/TW202123954A/zh unknown
-
2024
- 2024-04-09 JP JP2024062612A patent/JP2024098986A/ja active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1796388A (zh) * | 2004-12-28 | 2006-07-05 | 三得利株式会社 | 芝麻素/异芝麻素组合物 |
US20080275110A1 (en) * | 2004-12-28 | 2008-11-06 | Yoshiko Ono | Sesamin/Episesamin Compositions |
WO2009038089A1 (fr) * | 2007-09-19 | 2009-03-26 | Suntory Holdings Limited | Agent anti-fatigue contenant de la sésamine et de la vitamine e |
JP2009073749A (ja) * | 2007-09-19 | 2009-04-09 | Suntory Ltd | セサミン類とγ−オリザノールとを含有する組成物 |
CN101801370A (zh) * | 2007-09-19 | 2010-08-11 | 三得利控股株式会社 | 含有芝麻素类和花生四烯酸类的组合物 |
CN101868238A (zh) * | 2007-09-19 | 2010-10-20 | 三得利控股株式会社 | 配合有芝麻素类和维生素b1类的组合物 |
JP2015096494A (ja) * | 2013-10-07 | 2015-05-21 | かどや製油株式会社 | 生体内酸化還元状態改善剤 |
US20180071248A1 (en) * | 2015-03-23 | 2018-03-15 | Suntory Holdings Limited | Composition for improving circadian rhythm |
Also Published As
Publication number | Publication date |
---|---|
JP2024098986A (ja) | 2024-07-24 |
TW202123954A (zh) | 2021-07-01 |
JPWO2021065664A1 (fr) | 2021-04-08 |
WO2021065664A1 (fr) | 2021-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2680751C (fr) | Utiilisation de derives de diaxobicyclo[3.3.0]octane comme agent anti-fatigue | |
JP6095549B2 (ja) | リボフラビンとセサミン類とを含有する組成物 | |
KR101528381B1 (ko) | 세사민류와 비타민 b1 류를 배합한 조성물 | |
BG107038A (bg) | Гелен паразитициден състав | |
CN115867270A (zh) | 烟酰胺腺嘌呤二核苷酸(nad)浓度上升剂 | |
Rigos et al. | In vitro and in vivo evaluation of quinine in gilthead sea bream, Sparus aurata naturally infected with the ciliate Cryptocaryon irritans | |
CN114514022A (zh) | 维持生活活动量、预防其降低、抑制或改善其降低用组合物 | |
CN115867289A (zh) | 含有nr及/或nmn与芝麻素类的组合物 | |
DEMİRKAN et al. | Comparative study of butorphanol-ketamin HCl and xylazine-ketamin HCl combinations for their clinical and cardiovascular/respiratory effects in healthy dogs | |
KR20230079092A (ko) | 항피로용 조성물 및 에너지 생성능의 향상, 저하 억제 또는 유지를 위한 조성물 | |
US20180055848A1 (en) | Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia | |
WO2021065661A1 (fr) | Composition de suppression de la baisse de masse musculaire, prévention de la baisse à l'intérieur, son entretien, sa récupération ou son augmentation à l'intérieur | |
CN116999422A (zh) | 用于关节稳定性的β-羟基-β-甲基丁酸(HMB)的组合物和使用方法 | |
WO2017207600A1 (fr) | Nouveau traitement de la sma | |
McNamee et al. | Fenmetozole in acute alcohol intoxication in man | |
KR20210135835A (ko) | 움벨리페론을 유효성분으로 함유하는 외상 후 스트레스장애 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40075031 Country of ref document: HK |